Here are five things to know:
1. Amedica will help the company with proprietary design, development, manufacture and supply of silicon nitride spinal implants.
2. A biomaterial that contains anti-bacterial properties, silicon nitride can be shaped into complex designs and surfaces for various medical needs.
3. Sonny Bal, MD, JD, MBA, Amedica Chairman CEO, said the company is creating many OEM partnerships that will “lead to faster and more widespread market penetration of silicon nitride, positioning it as the biomaterial of choice for medical applications.”
4. Amedica develops and applies medical-grade silicon nitride ceramics and markets spinal fusion products.
5. Negotiations underlying the actual agreement will take place once all regulatory approvals are obtained without considerable expense.
More articles on devices:
Titan Spine, IlluminOss Medical, Stryker & more — 24 key notes
Stryker earnings skyrocket 206%: 10 key notes on 2Q
OptumRx and Catamaran combine to be pharmacy care powerhouse: 5 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
